Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 180Generated: October 25, 2026

2-[2-Chloro-5-(trifluoromethyl)pyridin-4-ylamino]-N-methylbenzamide → N-methyl-2-[[2-[[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]amino]-5-(trifluoromethyl)pyridin-4-yl]amino]benzamide

https://huagongshe.com/reaction/180

Reaction equation

Participants

RoleNameHCIDCharge
Reactant2-[2-Chloro-5-(trifluoromethyl)pyridin-4-ylamino]-N-methylbenzamideHCID 56655328—
Reactant1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-amine hydrochlorideHCID 75480753—
ReagentCesium carbonateHCID 10796—
Catalyst1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 636044—
CatalystPalladium (II) acetateHCID 4144353—
Solvent1,4-DioxaneHCID 31275—
ProductN-methyl-2-[[2-[[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]amino]-5-(trifluoromethyl)pyridin-4-yl]amino]benzamideHCID 8725962360.42%

Reaction Conditions

Temperature100 °C

Reaction Steps

2-(2-chloro-5-(trifluoromethyl)pyridin-4-ylamino)-N-methylbenzamide (100 mg, 0.30 mmol), 1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-amine hydrochloride (122 mg, 0.61 mmol), cesium carbonate (247 mg, 0.76 mmol), (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (28.1 mg, 0.05 mmol) and diacetoxypalladium (5.45 mg, 0.02 mmol) were suspended in dioxane (1.5 mL) and sealed into a tube. The reaction was degased, purged with nitrogen and heated to 100 °C for 18 hours. Reaction was filtered. The reaction mixture was purified by preparative HPLC using a Waters X-Bridge reverse-phase column (C-18, 5 microns silica, 19 mm diameter, 100 mm length, flow rate of 40 ml / minute) and decreasingly polar mixtures of water (containing 0.2% ammonium carbonate) and acetonitrile as eluent. The fractions containing the desired compound were evaporated to dryness to afford N-methyl-2-(2-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-ylamino)-5-(trifluoromethyl)pyridin-4-ylamino)benzamide (84 mg, 60.4 %) as a yellow crystalline solid.

Provenance & Evidence

Source dataset750 AstraZeneca ELN dataset
ORD IDord-db51fb4c9ca342c3a64870763aaddcf0
Source note750 AstraZeneca ELN dataset